<p>Silverback Therapeutics, Inc.（纳斯达克代码：SBTX - 获取免费报告）在周二的交易中股价下跌了 2.9%。该公司的股价最低曾达到 10.01 美元，最后交易价为 10.18 美元。在交易中共成交了 1,583,092 股，较平均交易量 337,931 股增加了 368%。该股票此前收盘价为 10.48 美元。</p>
<h2>Silverback Therapeutics 股票表现</h2>
<p>该股票的市值为 3.6707 亿美元，市盈率为-4.21，贝塔值为 0.60。该股票的 50 日移动平均价为 11.93 美元，200 日移动平均价为 13.10 美元。</p>
<h2>Silverback Therapeutics 公司简介</h2>
<p>（获取免费报告）</p>
<p>Silverback Therapeutics, Inc.是一家生物制药公司，开发针对慢性病毒感染、癌症和其他严重疾病的组织靶向治疗药物。该公司提供 SBT8230，用于通过靶向 TLR8 激活到肝脏来引发抗病毒免疫反应，从而治疗慢性乙型肝炎病毒感染。</p>
<h2>特色文章</h2>
<ul>
<li>我们更看好的五只股票超过 Silverback Therapeutics</li>
<li>为什么特别股息对收入投资者来说可能是一个令人愉快的惊喜</li>
<li>GitLab：在下跌时买入——大反弹即将到来</li>
<li>ETF 支付股息吗？你需要知道的事项</li>
<li>特斯拉股票：寻找底部可能需要时间</li>
<li>如何绘制斐波那契价格拐点水平</li>
<li>Duolingo：这只被打压的股票即将反弹 38%</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Silverback Therapeutics 吗？</h2>
<p>在考虑 Silverback Therapeutics 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 Silverback Therapeutics 并不在名单上。</p>
<p>虽然 Silverback Therapeutics 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

SBTX

<p>银背治疗公司（NASDAQ:SBTX）周二的交易中，股价下跌 2.9%，至 10.18 美元，交易量为 1,583,092 股，显著高于平均的 337,931 股。该公司的市值为 3.6707 亿美元，市盈率为-4.21。银背治疗公司开发针对慢性病毒感染和癌症的治疗药物，包括用于乙型肝炎的 SBT8230。分析师目前对该股票的评级为持有，但建议其他股票可能是更好的投资选择</p>

<p>Silverback Therapeutics, Inc. (NASDAQ:SBTX - Get Free Report) shares traded down 2.9% during trading on Tuesday . The company traded as low as $10.01 and last traded at $10.18. 1,583,092 shares were traded during trading, an increase of 368% from the average session volume of 337,931 shares. The stock had previously closed at $10.48.</p>
<div class="lb-trans"><p>Silverback Therapeutics, Inc.（纳斯达克代码：SBTX - 获取免费报告）在周二的交易中股价下跌了 2.9%。该公司的股价最低曾达到 10.01 美元，最后交易价为 10.18 美元。在交易中共成交了 1,583,092 股，较平均交易量 337,931 股增加了 368%。该股票此前收盘价为 10.48 美元。</p>
</div><h2>Silverback Therapeutics Stock Performance</h2>
<div class="lb-trans"><h2>Silverback Therapeutics 股票表现</h2>
</div><p>The stock has a market capitalization of $367.07 million, a P/E ratio of -4.21 and a beta of 0.60. The stock has a 50 day moving average of $11.93 and a 200 day moving average of $13.10.</p>
<div class="lb-trans"><p>该股票的市值为 3.6707 亿美元，市盈率为-4.21，贝塔值为 0.60。该股票的 50 日移动平均价为 11.93 美元，200 日移动平均价为 13.10 美元。</p>
</div><h2>Silverback Therapeutics Company Profile</h2>
<div class="lb-trans"><h2>Silverback Therapeutics 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.</p>
<div class="lb-trans"><p>Silverback Therapeutics, Inc.是一家生物制药公司，开发针对慢性病毒感染、癌症和其他严重疾病的组织靶向治疗药物。该公司提供 SBT8230，用于通过靶向 TLR8 激活到肝脏来引发抗病毒免疫反应，从而治疗慢性乙型肝炎病毒感染。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>特色文章</h2>
</div><ul>
<li>Five stocks we like better than Silverback Therapeutics</li>
<li>Why Special Dividends Can be a Delightful Surprise for Income Investors</li>
<li>GitLab: Get In While It’s Down—Big Rebound Ahead</li>
<li>Do ETFs Pay Dividends? What You Need to Know</li>
<li>Tesla Stock: Finding a Bottom May Take Time</li>
<li>How to Plot Fibonacci Price Inflection Levels</li>
<li>Duolingo: This Beaten-Down Stock Is About to Rally 38%</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过 Silverback Therapeutics</li>
<li>为什么特别股息对收入投资者来说可能是一个令人愉快的惊喜</li>
<li>GitLab：在下跌时买入——大反弹即将到来</li>
<li>ETF 支付股息吗？你需要知道的事项</li>
<li>特斯拉股票：寻找底部可能需要时间</li>
<li>如何绘制斐波那契价格拐点水平</li>
<li>Duolingo：这只被打压的股票即将反弹 38%</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Silverback Therapeutics Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Silverback Therapeutics 吗？</h2>
</div><p>Before you consider Silverback Therapeutics, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Silverback Therapeutics 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silverback Therapeutics wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 Silverback Therapeutics 并不在名单上。</p>
</div><p>While Silverback Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Silverback Therapeutics 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Silverback Therapeutics (NASDAQ:SBTX) 股价下跌 2.9% - 事情是这样的